Treatment satisfaction in postmenopausal women suboptimally adherent to bisphosphonates who transitioned to denosumab compared with risedronate or ibandronate.

Author: AgodoaIrene, BonnickSydney, BrownJacques P, FerreiraIrene, HoPei-Ran, PalaciosSantiago, Van den BerghJoop P

Paper Details 
Original Abstract of the Article :
CONTEXT: For many patients, adhering to postmenopausal osteoporosis treatment is a challenge. Higher treatment satisfaction is associated with greater persistence with these therapies, which is associated with better outcomes. OBJECTIVE: This study aimed to evaluate the change in treatment satisfac...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1210/jc.2014-3594

データ提供:米国国立医学図書館(NLM)

Denosumab: A New Option for Postmenopausal Osteoporosis

Postmenopausal osteoporosis is a common condition that can lead to fractures and other health complications. This study examines the treatment satisfaction of postmenopausal women who transitioned from suboptimally adherent oral bisphosphonates to denosumab compared to those who switched to monthly oral bisphosphonates. This research is crucial for understanding the potential benefits and challenges of different osteoporosis treatment options, particularly for patients with adherence issues.

Denosumab: Improved Treatment Satisfaction

The study found that women who transitioned to denosumab reported significantly greater improvements in treatment satisfaction compared to those who switched to monthly oral bisphosphonates. These findings suggest that denosumab may be a valuable option for women with low adherence to oral bisphosphonates, potentially leading to better treatment persistence and overall health outcomes.

Tailoring Osteoporosis Treatment: A Key to Success

Managing osteoporosis requires a personalized approach, considering factors like bone health, individual preferences, and treatment adherence. This study underscores the importance of tailoring treatment to meet individual needs, highlighting the potential of denosumab as a valuable option for women who struggle with adherence to oral bisphosphonates.

Dr.Camel's Conclusion

Think of a camel caravan traversing a desert, with each camel carrying its own unique burdens. Just as a camel needs to adapt its pace and strategy based on its load and the terrain, so too do individuals with osteoporosis need a personalized approach to treatment. This study offers a valuable oasis in the desert of osteoporosis management, reminding us that denosumab could be a powerful tool for improving treatment satisfaction and potentially leading to better outcomes for women who struggle with adherence to traditional medications.
Date :
  1. Date Completed 2015-05-12
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

25514106

DOI: Digital Object Identifier

10.1210/jc.2014-3594

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.